Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lunar Helium-3 Mining, LLC (LH3M) is an aerospace and resource development company focused on the detection, extraction, and return of Helium-3 from the Moon. Founded by Dr. Chris Salvino, a former trauma surgeon with multiple degrees in engineering and geology, the company addresses the critical terrestrial shortage of Helium-3, which is essential for advanced medical imaging, quantum computing, and clean fusion energy. LH3M holds a robust portfolio of 11 U.S. patents covering end-to-end systems for lunar regolith processing and gas refinement. Its primary medical application is providing hyperpolarized Helium-3 for high-resolution MRI of the lungs to diagnose and treat conditions like asthma and cystic fibrosis. The company is currently in the development phase, advancing its technology readiness levels and establishing strategic partnerships for lunar missions. LH3M aims to create the first sustainable Moon-to-Earth supply chain for this multi-trillion-dollar resource.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lunar Helium-3 Mining.